Skip to main content
Equibles

Caption Management, LLC

Position in IDYA — IDEAYA Biosciences, Inc.

CIK 1706766 OKLAHOMA CITY, OK
Back to IDYA Full portfolio

Position in IDYA

as of Jun 30, 2026 · filed Aug 14, 2026
Position Value
$1,137,815
+$1,137,815 QoQ
Shares Held
30,529
Ownership
0.032%
of shares outstanding
% of Portfolio
0.05%
of 13F equity value
Holder Rank
#132
of 286 holders
Holding Since
Mar 2025
6 quarters on record
Voting authority Sole 100% Shared 0% None 0%

Common Shares in IDYA Over Time

Shares Held

Position Value (USD)

Derivatives in IDYA

reported options exposure · as of Mar 31, 2026
CallValue
$32,580,296
CallShares
977,800
PutValue
$3,305,344
PutShares
99,200

Notional value of option positions as reported on Form 13F. Calls and puts are disclosed separately and do not net against the common-share stake above.

Position in Biotechnology

Healthcare · as of Jun 30, 2026

Caption Management, LLC holds $249,760,911 across 78 Biotechnology names. IDYA ranks #41 (0.5% of the industry book) .

# Ticker Company Shares Value (USD) Open
1 CGON
CG Oncology, Inc.
 484,461 $34,420,954
2 INSM
INSMED Inc
 236,000 $25,162,320
3 ERAS
Erasca, Inc.
 1,041,225 $19,075,242
4 CELC
Celcuity Inc.
 170,000 $17,785,400
5 DSGN
Design Therapeutics, Inc.
 1,118,098 $16,178,878
6 MLYS
Mineralys Therapeutics, Inc.
 413,087 $11,145,087
7 REPL
Replimune Group, Inc.
 783,873 $8,677,474
8 TARS
Tarsus Pharmaceuticals, Inc.
 120,700 $7,596,858

All Filings in IDYA

Export CSV
10 filing rows on record
Report Date Value (USD) Shares
2026-06-30 $1,137,815 30,529
2026-03-31 $32,580,296 977,800
2026-03-31 $3,305,344 99,200
2025-12-31 $1,976,263 57,167
2025-12-31 $15,556,500 450,000
2025-09-30 $1,904,700 70,000
2025-09-30 $530,595 19,500
2025-06-30 $1,156,100 55,000
2025-06-30 $210,200 10,000
2025-03-31 $443,898 27,100